Cameron Turtle

SYRE

Cameron Turtle serves as director, officer: Chief Executive Officer at Spyre Therapeutics, Inc. (SYRE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

5 trades

$3.18M

Net Position

Net Seller

$3.18M

Companies Traded

SYRE

Active Period

Nov 2025 – Apr 2026

5 total trades

Most Recent

Sell SYRE

Apr 3, 2026 · $739.9K

Cameron Turtle's Insider Trading at Spyre Therapeutics, Inc. (SYRE)

Buys

0 · $0.00

Sells

5 · $3.18M

Total Shares Bought

Total Shares Sold

105,000

SYRE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Apr 3, 2026	Sell	15,000	$49.33	$739.9K	630,196
Feb 2, 2026	Sell	15,000	$32.80	$492.0K	0
Jan 2, 2026	Sell	15,000	$30.68	$460.1K	0
Dec 1, 2025	Sell	15,000	$29.02	$435.4K	0
Nov 3, 2025	Sell	45,000	$23.33	$1.05M	0

Related Insiders

Scott L Burrows

officer: Chief Financial Officer

SYRESell · Apr 3, 2026

Sheldon Sloan

officer: Chief Medical Officer

SYRESell · Apr 3, 2026

Explore More Insider Trading Data

SYRE Insider Trading Activity

View all insider trades at Spyre Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity